Bio Soft Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 10 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -65.57%
(FY 2022)
- Profit -195.20%
(FY 2022)
- Ebitda -195.20%
(FY 2022)
- Net Worth -4.16%
(FY 2022)
- Total Assets 116.88%
(FY 2022)
About Bio Soft Research
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagan Male and Sujana Vaka serve as directors at the Company.
- CIN/LLPIN
U72200TG2014PTC096973
- Company No.
096973
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2014
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bio Soft Research Private Limited offer?
Bio Soft Research Private Limited offers a wide range of products and services, including Copywriting & Content Development, Content Writing Service, ISO & Quality Management Consultants, Certification Services, IT, Networking & Automation Solution, IT Solutions, Data Entry & Data Processing Service, Data Management, Graduation & High Education Programs, Medical Educational Service.
Who are the key members and board of directors at Bio Soft Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagan Male  | Director | 24-Dec-2014 | Current |
| Sujana Vaka | Director | 24-Dec-2014 | Current |
Financial Performance of Bio Soft Research.
Bio Soft Research Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 65.57% decrease. The company also saw a substantial fall in profitability, with a 195.2% decrease in profit. The company's net worth dipped by a decrease of 4.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Soft Research?
In 2021, Bio Soft Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Soft Research?
Unlock and access historical data on people associated with Bio Soft Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Soft Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Soft Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
